Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
Practice environmental safety in Style: Divulging Famous Electric Vehicle Brands - 2Huge solar flare no threat to Artemis 2 astronaut launch to the moon, NASA says
- 3Nepal’s youngest premier sworn in after releasing new rap song about unity
- 4UK to hold fresh pork, other affected Spanish products at border amid African swine fever outbreak
- 5Oil rises above $115 and Asia stocks slide as Iran war escalates
- the Kinds of Thailand: Decision in favor of Your Number one Thai Dish!
- 6 Well known Ladies' Fragrances On the planet
- Italy's Beloved Trevi Fountain Hides A Unique Secret That Can Be Explored Underground
- Concern for couple jailed in Tehran as British embassy closes
- Russia confirms 16 Cameroonian soldiers killed in Ukraine war
- Merz says army could be involved in mine-clearing from Hormuz
- Latvia seeks emergency UN meeting over Russian missile attack on Lviv
- Worldwide Objections Ideal For A Golf Outing
- Most loved Public Dish: Which One Addresses Its Nation Best?
